Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 5
1979 8
1980 5
1981 4
1982 13
1983 11
1984 3
1985 5
1986 9
1987 7
1988 7
1989 8
1990 5
1991 4
1992 14
1993 16
1994 8
1995 13
1996 10
1997 17
1998 6
1999 6
2000 6
2001 6
2002 8
2003 8
2004 8
2005 12
2006 8
2007 2
2008 5
2009 3
2010 7
2011 2
2012 1
2013 3
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

262 results
Results by year
Filters applied: . Clear all
Page 1
[Silent ischemia].
Bauters C, Quandalle P, Lablanche JM, McFadden E, Bertrand M. Bauters C, et al. Among authors: lablanche jm. Rev Med Interne. 1994 Jan;15(1):37-42. doi: 10.1016/s0248-8663(05)82128-9. Rev Med Interne. 1994. PMID: 8052752 Review. French.
Restenosis after coronary angioplasty.
Hamon M, Bauters C, McFadden EP, Wernert N, Lablanche JM, Dupuis B, Bertrand ME. Hamon M, et al. Among authors: lablanche jm. Eur Heart J. 1995 Aug;16 Suppl I:33-48. doi: 10.1093/eurheartj/16.suppl_i.33. Eur Heart J. 1995. PMID: 8829956 Review.
Potassium channel activators in vasospastic angina.
Lablanche JM, Bauters C, McFadden EP, Quandalle P, Bertrand ME. Lablanche JM, et al. Eur Heart J. 1993 Jul;14 Suppl B:22-4. doi: 10.1093/eurheartj/14.suppl_b.22. Eur Heart J. 1993. PMID: 8370368 Review.
[Other techniques of arterial recanalization].
Lablanche JM, Bauters C, Leroy F, Bertrand ME. Lablanche JM, et al. Rev Prat. 1990 Nov 11;40(26):2455-60. Rev Prat. 1990. PMID: 2277938 Review. French.
Role of endothelial cells in restenosis after coronary angioplasty.
Meurice T, Vallet B, Bauters C, Dupuis B, Lablanche JM, Bertrand ME. Meurice T, et al. Among authors: lablanche jm. Fundam Clin Pharmacol. 1996;10(3):234-42. doi: 10.1111/j.1472-8206.1996.tb00302.x. Fundam Clin Pharmacol. 1996. PMID: 8836697 Review.
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. Fruchart JC, et al. Among authors: lablanche jm. Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K. doi: 10.1016/S0002-9149(08)01833-X. Am J Cardiol. 2008. PMID: 19068318 Review.
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P; Residual Risk Reduction Initiative (R3I). Fruchart JC, et al. Among authors: lablanche jm. Diab Vasc Dis Res. 2008 Nov;5(4):319-35. doi: 10.3132/dvdr.2008.046. Diab Vasc Dis Res. 2008. PMID: 18958843 Free article. Review.
262 results